saxenda glp-1 medications (Liraglutide) Teva brings first generic GLP-1

Patients often report not only weight loss but also improvements in energy, motivation, and their relationship with food

Discussion In our present study, we identified the causal role of GLP-1R-based agonists in reducing the risk of MASLD and its metabolic risk factors, including HDL-C, TG, and ISI, partly independent of the weight-loss effect

This article explores evidence-based strategiesincluding specific foods, eating patterns, physical activity, and sleep optimisationthat may support your body's own GLP-1 production as part of a holistic approach to metabolic wellbeing

Noom reports 70% of members experience no side effects versus higher rates with full-dose treatment, potentially improving medication adherence and allowing patients to stick with their treatment plans longer

Send us your press releases and announcements